Glucose is an important source of energy and carbon, and is required for cell growth. As such, glucose utilization is increased in rapidly dividing cancer cells. The tumour suppressor p53 has now been reported to block a metabolic pathway (the pentose phosphate pathway) that diverts glucose away from bioenergetic into biosynthetic routes.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Tennant, D. A., Duran, R. V., Boulahbel, H. & Gottlieb, E. Carcinogenesis 30, 1269–1280 (2009).
Vander Heiden, M. G., Cantley, L. C. & Thompson, C. B. Science 324, 1029–1033 (2009).
Tennant, D. A., Duran, R. V. & Gottlieb, E. Nat. Rev. Cancer 10, 267–277 (2010).
Levine, A. J. & Puzio-Kuter, A. M. Science 330, 1340–1344 (2010).
Gottlieb, E. & Vousden, K. H. Cold Spring Harb. Perspect. Biol. 2, a001040 (2010).
Jiang, P. et al. Nat. Cell Biol. 13, doi: 10.1038/ncb2172 (2011).
Brahimi-Horn, M. C., Bellot, G. & Pouyssegur, J. Curr. Opin. Genet. Dev. doi:10.1016/j.gde.2010.10.006 (in the press).
Bensaad, K. et al. Cell 126, 107–120 (2006).
Herrero-Mendez, A. et al. Nat. Cell Biol. 11, 747–752 (2009).
Schafer, Z. T. et al. Nature 461, 109–113 (2009).
Duvel, K. et al. Mol. Cell 39, 171–183 (2010).
Li, H. & Jogl, G. J. Biol. Chem. 284, 1748–1754 (2009).
Green, D. R. & Kroemer, G. Nature 458, 1127–1130 (2009).
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Gottlieb, E. p53 guards the metabolic pathway less travelled. Nat Cell Biol 13, 195–197 (2011). https://doi.org/10.1038/ncb2177
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncb2177
This article is cited by
-
High expression levels of pyrimidine metabolic rate–limiting enzymes are adverse prognostic factors in lung adenocarcinoma: a study based on The Cancer Genome Atlas and Gene Expression Omnibus datasets
Purinergic Signalling (2020)
-
Prognostic role of glycolysis for cancer outcome: evidence from 86 studies
Journal of Cancer Research and Clinical Oncology (2019)
-
Vital staining with iodine solution in oral cancer: iodine infiltration, cell proliferation, and glucose transporter 1
International Journal of Clinical Oncology (2013)